Zacks Research Issues Pessimistic Estimate for THC Earnings

Tenet Healthcare Co. (NYSE:THC) – Research analysts at Zacks Research decreased their Q2 2026 earnings estimates for Tenet Healthcare in a note issued to investors on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3.33 per share for the quarter, down from their prior estimate of $3.34. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2026 earnings at $3.08 EPS.

THC has been the topic of a number of other research reports. Truist Financial dropped their price target on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp cut their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reissued an “overweight” rating and set a $175.00 price objective on shares of Tenet Healthcare in a report on Tuesday, December 17th. StockNews.com upgraded Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, March 13th. Finally, TD Cowen assumed coverage on Tenet Healthcare in a report on Wednesday, February 26th. They issued a “buy” rating and a $175.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $166.41.

Tenet Healthcare Stock Up 1.2 %

Shares of THC stock opened at $134.70 on Monday. The stock’s fifty day moving average price is $132.51 and its 200 day moving average price is $142.15. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. Tenet Healthcare has a 1-year low of $90.03 and a 1-year high of $171.20. The company has a market cap of $12.81 billion, a price-to-earnings ratio of 4.18, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Insider Activity

In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the sale, the director now directly owns 27,378 shares of the company’s stock, valued at $3,434,022.54. The trade was a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.93% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Tenet Healthcare in the fourth quarter worth about $190,819,000. Wealthfront Advisers LLC acquired a new position in shares of Tenet Healthcare during the 4th quarter worth approximately $69,059,000. Geode Capital Management LLC grew its position in shares of Tenet Healthcare by 23.6% in the third quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company’s stock valued at $339,893,000 after purchasing an additional 390,316 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Tenet Healthcare during the fourth quarter worth approximately $49,001,000. Finally, Renaissance Technologies LLC boosted its stake in Tenet Healthcare by 579.2% during the fourth quarter. Renaissance Technologies LLC now owns 438,563 shares of the company’s stock worth $55,360,000 after buying an additional 373,988 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.